Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2022 Feb 9;13(2):133. doi: 10.1038/s41419-022-04558-6

Correction: LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212

Fujun Yu 1,#, Wujun Geng 2,#, Peihong Dong 3,, Zhiming Huang 1,, Jianjian Zheng 4,
PMCID: PMC8828875  PMID: 35140199

Correction to: Cell Death and Disease 10.1038/s41419-018-1068-x, published online 03 October 2018

The original version of this article unfortunately contained a mistake in Fig. 1A and Fig. 3D.

Fig. 1.

Fig. 1

▓.

Fig. 3.

Fig. 3

▓.

In the original Fig. 1A, an incorrect image for the α-SMA immunocytochemical staining panel was inadvertently included. As shown in α-SMA staining in Fig. 1A, the image of 4-week CCl4 mice (mice were treated CCl4 for 4 weeks) was uploaded as the CCl4 mice (CCl4 mice should be treated CCl4 for 8 weeks). In the original Fig. 3D, the cell migration image of Ad-Ctrl group was wrongly uploaded as Ad-MEG3 group. The corrected images are provided below. The authors confirm that these errors do not affect the results and conclusions of the study. The authors apologize for any inconvenience caused.

Contributor Information

Peihong Dong, Email: dongpeihong111@163.com.

Zhiming Huang, Email: zhimhuan@163.com.

Jianjian Zheng, Email: 120378196@qq.com.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES